Yedid Elbez
About
Yedid Elbez is a scholar working on Cardiology and Cardiovascular Medicine, Rheumatology and Surgery.
According to data from OpenAlex, Yedid Elbez has authored 58 papers receiving a total of 941 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 16 papers in Rheumatology and 14 papers in Surgery. Recurrent topics in Yedid Elbez's work include Rheumatoid Arthritis Research and Therapies (14 papers), Antiplatelet Therapy and Cardiovascular Diseases (12 papers) and Acute Myocardial Infarction Research (12 papers). Yedid Elbez is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (14 papers), Antiplatelet Therapy and Cardiovascular Diseases (12 papers) and Acute Myocardial Infarction Research (12 papers). Yedid Elbez collaborates with scholars based in United States, France and United Kingdom. Yedid Elbez's co-authors include Philippe Gabríel Steg, Deepak L. Bhatt, Kim A. Eagle, Grégory Ducrocq, Shinya Goto, Christopher P. Cannon, Emmanuel Sorbets, Iris Baumgärtner, Sidney C. Smith and Mark A. Creager and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.
In The Last Decade
Yedid Elbez
56 papers receiving 922 citations
Peers
Yedid Elbez
Eralp Tutar Türkiye
Khagendra Dahal United States
Lars Lindhagen Sweden
Gabriella Iannuzzo Italy
Shuta Tsuboi Japan
Axel Åkerblom Sweden
Takashi Miura Japan
Manabu Ogita Japan
Vikas Veeranna United States
Matteo Nardin Italy
Citations per year, relative to Yedid Elbez Yedid Elbez (= 1×)
peers
Eralp Tutar
Countries citing papers authored by Yedid Elbez
Since
Specialization
Citations
This map shows the geographic impact of Yedid Elbez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yedid Elbez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yedid Elbez more than expected).
Fields of papers citing papers by Yedid Elbez
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Yedid Elbez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yedid Elbez. The network helps show where Yedid Elbez may publish in the future.
Co-authorship network of co-authors of Yedid Elbez
This figure shows the co-authorship network connecting the top 25 collaborators of Yedid Elbez. A scholar is included among the top collaborators of Yedid Elbez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yedid Elbez. Yedid Elbez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Picard, Fabien, Grégory Ducrocq, Yedid Elbez, et al.. (2023). New-onset atrial fibrillation and chronic coronary syndrome in the CLARIFY registry. European Heart Journal. 45(5). 366–375.
2.
Vidal‐Petiot, Emmanuelle, Yedid Elbez, Jules Mesnier, et al.. (2023). Optimal or standard control of systolic and diastolic blood pressure across risk factor categories in patients with chronic coronary syndromes. European Journal of Preventive Cardiology. 30(10). 935–947.
3.
Emery, Paul, Yoshiya Tanaka, Vivian P. Bykerk, et al.. (2023). The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study. Arthritis Research & Therapy. 25(1). 67–67.
4.
Baker, Joshua F., Philip G. Conaghan, Paul Emery, et al.. (2022). Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abatacept. Arthritis Research & Therapy. 24(1). 47–47.
5.
Popovic, Batric, Grégory Ducrocq, Yedid Elbez, et al.. (2022). Clinical Significance of Culprit Vessel Occlusion in Patients With Non–ST-Elevation Myocardial Infarction Who Underwent Percutaneous Coronary Intervention. The American Journal of Cardiology. 188. 95–101.
6.
Alten, Rieke, Xavier Mariette, René‐Marc Flipo, et al.. (2021). OP0180 IMPACT OF RF AND ANTI-CITRULLINATED PROTEIN ANTIBODY SEROSTATUS ON 2-YEAR RETENTION OF ABATACEPT IN PATIENTS WITH RA. Annals of the Rheumatic Diseases. 80. 108–108.
7.
Abtan, Jérémie, Stephen D. Wiviott, Emmanuel Sorbets, et al.. (2021). Prevalence, clinical determinants and prognostic implications of coronary procedural complications of percutaneous coronary intervention in non-ST-segment elevation myocardial infarction: Insights from the contemporary multinational TAO trial. Archives of cardiovascular diseases. 114(3). 187–196.
8.
Ducrocq, Grégory, Yedid Elbez, Batric Popovic, et al.. (2021). Prevalence, Incidence and Prognostic Implications of Left Bundle Branch Block in Patients with Chronic Coronary Syndromes (From the CLARIFY Registry). The American Journal of Cardiology. 150. 40–46.
9.
Westhovens, René, Seán Connolly, Yedid Elbez, et al.. (2020). Up to 5-year retention of abatacept in Belgian patients with moderate-to-severe rheumatoid arthritis: a sub-analysis of the international, observational ACTION study. Rheumatology International. 40(9). 1409–1421.
10.
Alten, Rieke, Eugen Feist, Hanns‐Martin Lorenz, et al.. (2019). Abatacept retention and clinical outcomes in rheumatoid arthritis: real-world data from the German cohort of the ACTION study and a comparison with other participating countries. Clinical Rheumatology. 38(11). 3049–3059.
11.
Peichl, P., Rieke Alten, Mauro Galeazzi, et al.. (2019). Abatacept retention and clinical outcomes in Austrian patients with rheumatoid arthritis: real-world data from the 2-year ACTION study. Wiener Medizinische Wochenschrift. 170(5-6). 132–140.
12.
Sorbets, Emmanuel, Grégory Ducrocq, Yedid Elbez, et al.. (2018). Identifying higher risk patients among the COMPASS-Eligible population: An analysis from the REduction of Atherothrombosis for Continued Health (REACH) Registry. Archives of Cardiovascular Diseases Supplements. 11(1). 6–7.
13.
Adjedj, Julien, Grégory Ducrocq, Claire Bouleti, et al.. (2017). Medical Student Evaluation With a Serious Game Compared to Multiple Choice Questions Assessment. JMIR Serious Games. 5(2). e11–e11.
14.
Bavry, Anthony A., Islam Y. Elgendy, Yedid Elbez, et al.. (2017). Aspirin and the risk of cardiovascular events in atherosclerosis patients with and without prior ischemic events. Clinical Cardiology. 40(9). 732–739.
15.
Varshney, Anubodh S., Philippe Gabríel Steg, Yedid Elbez, et al.. (2017). Examining the applicability of SPRINT in patients with subclinical or established atherothrombotic disease: A REACH registry analysis. International Journal of Cardiology. 243. 95–97.
16.
Selvaraj, Senthil, Philippe Gabríel Steg, Yedid Elbez, et al.. (2016). Pulse Pressure and Risk for Cardiovascular Events in Patients With Atherothrombosis. Journal of the American College of Cardiology. 67(4). 392–403.
17.
Hansel, Boris, Ronan Roussel, Yedid Elbez, et al.. (2015). Cardiovascular risk in relation to body mass index and use of evidence-based preventive medications in patients with or at risk of atherothrombosis. European Heart Journal. 36(40). 2716–2728.
18.
Elbez, Yedid, Amir-Ali Fassa, Eric A. Cohen, et al.. (2015). Clinical outcomes in patients with stable coronary artery disease with vs. without a history of myocardial revascularization. European Heart Journal - Quality of Care and Clinical Outcomes. 2(1). 23–32.
19.
Kumbhani, Dharam J., Philippe Gabríel Steg, Christopher P. Cannon, et al.. (2014). Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. European Heart Journal. 35(41). 2864–2872.
20.
Elbez, Yedid, Shlomit Farkash-Amar, & Itamar Simon. (2006). An analysis of intra array repeats: the good, the bad and the non informative. BMC Genomics. 7(1). 136–136.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Eralp Tutar Breakdown of academic impact, for papers by Khagendra Dahal Breakdown of academic impact, for papers by Lars Lindhagen Breakdown of academic impact, for papers by Gabriella Iannuzzo Breakdown of academic impact, for papers by Shuta Tsuboi Breakdown of academic impact, for papers by Axel Åkerblom Breakdown of academic impact, for papers by Takashi Miura Breakdown of academic impact, for papers by Manabu Ogita Breakdown of academic impact, for papers by Vikas Veeranna Breakdown of academic impact, for papers by Matteo Nardin